EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

The Cystic Fibrosis Transmembrane Conductance Receptor Brakes Allergic Airway Inflammation

Daniel P Cook, R Stokes Peebles iD

Immunological Reviews · 2025

DOI: 10.1111/imr.70009 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Immunological Reviews, 2025. Verfasst von Daniel P Cook und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Critical Care and Occupational Medicine, University of Iowa Carver School of Medicine, Iowa City, Iowa, USA. Hauptthemen laut MEDLINE: Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, Th2 Cells, Inflammation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, Francis Family Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cystic fibrosis (CF) is a common autosomal recessive disease resulting from mutations of the gene that encodes the cystic fibrosis transmembrane conductance regulator (CFTR). Although severe pulmonary neutrophilic inflammation is a primary pathologic feature of CF, more recent studies reveal a role for type 2 inflammation that is characterized by eosinophilia directed by both the innate and adaptive immune systems through ILC2 and CD4 + Th2 cells, respectively. We have published that a clear type endotype exists within CF subjects stratified by Th2 inflammation, defined by increased obstructive pulmonary disease and a distinct phenotypic signature of increased allergic disease, infections, and burden of CF complications. Further, we showed an increased risk of death among CF subjects with type 2 inflammatory signatures compared to CF subjects lacking significant type 2 inflammation. The mechanisms of this heightened type 2 inflammatory signature in CF are still being defined, but it is clear that airway epithelial cells from CFTR‐deficient mice have increased expression and release of IL‐33, a key activator of ILC2 and Th2 cells, compared to persons with normal CFTR function. Further, there is strong evidence that CF regulates CD4 + Th2 function in a cell‐intrinsic fashion. These concepts are explored in this review article.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorTh2 CellsInflammationHypersensitivityHumansAnimalsImmunity, InnateMiceInterleukin-33

Stichwörter der Autor:innen

CD4+ Th2 lymphocytesGATA‐3ILC2IL‐33cystic fibrosisepithelial cell

Substanzen

Cystic Fibrosis Transmembrane Conductance RegulatorInterleukin-33

Autor:innen und Institutionen

  • Division of Pulmonary, Critical Care and Occupational Medicine, University of Iowa Carver School of Medicine, Iowa City, Iowa, USA.
  • Division of Allergy, Pulmonary, and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA.
  • United States Department of Veterans Affairs, Nashville, Tennessee, USA.

ORCID-Profile: R Stokes Peebles

Förderung

  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • Francis Family Foundation
  • BLRD VA
  • U.S. Department of Veterans Affairs
  • Cystic Fibrosis Foundation

Zitieren

APA

Cook, D. P., & Peebles, R. S. (2025). The Cystic Fibrosis Transmembrane Conductance Receptor Brakes Allergic Airway Inflammation. Immunological Reviews. https://doi.org/10.1111/imr.70009

Vancouver

Cook DP, Peebles RS. The Cystic Fibrosis Transmembrane Conductance Receptor Brakes Allergic Airway Inflammation. Immunological Reviews. 2025. doi:10.1111/imr.70009

BibTeX
@article{Cook2025,
  author = {Cook, Daniel P and Peebles, R Stokes},
  title = {The Cystic Fibrosis Transmembrane Conductance Receptor Brakes Allergic Airway Inflammation},
  journal = {Immunological Reviews},
  year = {2025},
  doi = {10.1111/imr.70009}
}
Kostenlos starten →